Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
The Future of Targeting FLT3 Activation in AML
HTML
Details
Locations
Year:
2017
Type:
review
Source:
Current Hematologic Malignancy Reports
DOI:
10.1007/s11899-017-0381-2
Authors:
Mark B. Leick,
Mark J. Levis
Institutions:
Johns Hopkins University,
Johns Hopkins Hospital,
Sidney Kimmel Comprehensive Cancer Center
Language:
English
Topic:
Acute Myeloid Leukemia Research
Subfield:
Hematology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2606815299
FWCI:
1.08
Cites:
112
Cited by:
43
Related to:
10